FDA — authorised 3 December 1957
- Application: NDA011161
- Marketing authorisation holder: ASTELLAS
- Local brand name: ARISTOCORT
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Kenalog and Sensorcaine in United States
FDA authorised Kenalog and Sensorcaine on 3 December 1957
Marketing authorisations
FDA — authorised 11 March 1974
- Application: ANDA083750
- Marketing authorisation holder: IVAX SUB TEVA PHARMS
- Local brand name: TRIAMCINOLONE
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 22 April 1975
- Application: ANDA084340
- Marketing authorisation holder: IMPAX LABS
- Local brand name: TRIAMCINOLONE
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 16 October 1975
- Application: ANDA084268
- Marketing authorisation holder: BARR
- Local brand name: TRIAMCINOLONE
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 21 October 1975
- Application: ANDA084319
- Marketing authorisation holder: BARR
- Local brand name: TRIAMCINOLONE
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 22 October 1975
- Application: ANDA084267
- Marketing authorisation holder: BARR
- Local brand name: TRIAMCINOLONE
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 22 October 1975
- Application: ANDA084318
- Marketing authorisation holder: BARR
- Local brand name: TRIAMCINOLONE
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 22 October 1975
- Application: ANDA084320
- Marketing authorisation holder: BARR
- Local brand name: TRIAMCINOLONE
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 4 November 1975
- Application: ANDA084286
- Marketing authorisation holder: BARR
- Local brand name: TRIAMCINOLONE
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 8 February 1977
- Application: ANDA084270
- Marketing authorisation holder: WATSON LABS
- Local brand name: TRIAMCINOLONE
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 30 July 1982
- Application: ANDA085601
- Marketing authorisation holder: SANDOZ
- Local brand name: TRIAMCINOLONE
- Indication: TABLET — ORAL
- Status: approved
FDA
- Application: ANDA084020
- Marketing authorisation holder: PUREPAC PHARM
- Local brand name: TRIAMCINOLONE
- Indication: TABLET — ORAL
- Status: approved
FDA
- Application: ANDA084708
- Marketing authorisation holder: ROXANE
- Local brand name: TRIAMCINOLONE
- Indication: TABLET — ORAL
- Status: approved
FDA
- Application: ANDA084709
- Marketing authorisation holder: ROXANE
- Local brand name: TRIAMCINOLONE
- Indication: TABLET — ORAL
- Status: approved
FDA
- Application: ANDA084406
- Marketing authorisation holder: MYLAN
- Local brand name: TRIAMCINOLONE
- Indication: TABLET — ORAL
- Status: approved
FDA
- Application: ANDA084775
- Marketing authorisation holder: TEVA
- Local brand name: TRIAMCINOLONE
- Indication: TABLET — ORAL
- Status: approved
FDA
- Application: ANDA084707
- Marketing authorisation holder: ROXANE
- Local brand name: TRIAMCINOLONE
- Indication: TABLET — ORAL
- Status: approved
Frequently asked questions
Is Kenalog and Sensorcaine approved in United States?
Yes. FDA authorised it on 3 December 1957; FDA authorised it on 11 March 1974; FDA authorised it on 22 April 1975.
Who is the marketing authorisation holder for Kenalog and Sensorcaine in United States?
ASTELLAS holds the US marketing authorisation.